MDMA DOA at FDA Advisory Committee

By Hillary Campbell & Whitt Steineker on June 20, 2024 Avid readers know we have speculated that the legalization of psychedelics as a prescription medicine was “closer than ever.” Unfortunately, for proponents of the legalization of psychedelics like MDMA, progress is rarely a straight line. As we previously reported, Lykos Therapeutics Inc. sponsored a new drug application for MDMA therapy. That […]